Dae Yeol LeeDae Y. Lee received his doctorate degree in 2009 from the Rutgers University, Ernest Mario School of Pharmacy (Pharm.D).  He received his J.D. in 2012 from the Maurice A. Deane School of Law at Hofstra University.

Prior to joining the Firm, Mr. Lee represented injured consumers in pharmaceutical litigation at a Manhattan law firm, where he was involved in case development and investigation, as well as all aspects of pre-trial litigation.

Mr. Lee is active in the Firm’s mass tort practice and works on a wide array of pharmaceutical, medical device, and, consumer injury cases. Mr. Lee’s experience as a pharmacist gives him a unique advantage in representing consumers injured by dangerous drugs.  Currently, he is litigating cases involving diabetes medications and the medication Fresenius Granuflo/Naturalyte dialysate, as well as cases involving Risperdal and Testosterone Supplements, Power Morcellator, and Actos.  He is also investigating cases involving Fluoroquinolones, SGLT-2 diabetes drugs, Forced Air Warmer, and Zimmer Persona knee implants.

Mr. Lee is admitted to the Bars of the State of New York and New Jersey.

Published July 5, 2013 by